CASSAVA SCIENCES INC
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
FLNA$0.45+0.4%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements Condensed Consolidated Balance Sheets – September 30, 2024 and December 31, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, In thousands, except share and par value data)
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $148,978 | $121,136 |
| Restricted cash | 40,000 | — |
| Prepaid expenses and other current assets | 13,571 | 8,497 |
| Total current assets | 202,549 | 129,633 |
| Property and equipment, net | 21,135 | 21,854 |
| Intangible assets, net | 69 | 176 |
| Total assets | $223,753 | $151,663 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $52,244 | $10,573 |
| Accrued development expense | 2,543 | 3,037 |
| Accrued compensation and benefits | 1,950 | 200 |
| Other current liabilities | 297 | 385 |
| Total current liabilities | 57,034 | 14,195 |
| Other non-current liabilities | 80 | — |
| Total liabilities | 57,114 | 14,195 |
| Commitments and contingencies (Notes 9, 10 and 11) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued and outstanding | — | — |
| Common stock, $0.001 par value; 120,000,000 shares authorized; 47,976,166 and 42,236,919 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively | 48 | 42 |
| Additional paid-in capital | 544,105 | 518,195 |
| Accumulated deficit | (377,514) | (380,769) |
| Total stockholders' equity | 166,639 | 137,468 |
| Total liabilities and stockholders' equity | $223,753 | $151,663 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.